Journal of Cardiovascular Development and Disease (Feb 2022)

DCHS1, Lix1L, and the Septin Cytoskeleton: Molecular and Developmental Etiology of Mitral Valve Prolapse

  • Kelsey S. Moore,
  • Reece Moore,
  • Diana B. Fulmer,
  • Lilong Guo,
  • Cortney Gensemer,
  • Rebecca Stairley,
  • Janiece Glover,
  • Tyler C. Beck,
  • Jordan E. Morningstar,
  • Rachel Biggs,
  • Rupak Muhkerjee,
  • Alexander Awgulewitsch,
  • Russell A. Norris

DOI
https://doi.org/10.3390/jcdd9020062
Journal volume & issue
Vol. 9, no. 2
p. 62

Abstract

Read online

Mitral valve prolapse (MVP) is a common cardiac valve disease that often progresses to serious secondary complications requiring surgery. MVP manifests as extracellular matrix disorganization and biomechanically incompetent tissues in the adult setting. However, MVP has recently been shown to have a developmental basis, as multiple causal genes expressed during embryonic development have been identified. Disease phenotypes have been observed in mouse models with human MVP mutations as early as birth. This study focuses on the developmental function of DCHS1, one of the first genes to be shown as causal in multiple families with non-syndromic MVP. By using various biochemical techniques as well as mouse and cell culture models, we demonstrate a unique link between DCHS1-based cell adhesions and the septin-actin cytoskeleton through interactions with cytoplasmic protein Lix1-Like (LIX1L). This DCHS1-LIX1L-SEPT9 axis interacts with and promotes filamentous actin organization to direct cell-ECM alignment and valve tissue shape.

Keywords